Literature DB >> 22621986

Influence of hapten density on immunogenicity for anti-ciprofloxacin antibody production in mice.

Kun Hu1, Xuanyun Huang, Yousheng Jiang, Junqiang Qiu, Wei Fang, Xianle Yang.   

Abstract

To generate antibodies against small molecules, it is necessary to couple them as haptens to large carriers such as proteins. However, the immunogenicity of the conjugates usually has no linear correlation with the hapten-protein ratio, which may lead to large variations in the character of the desired antibodies. In the present study, ciprofloxacin (CPFX) was coupled to bovine serum albumin (BSA) in five different proportions using a modified carbodiimide method. The conjugates were characterized qualitatively by spectrophotometric absorption and electrophoresis methods. Mass spectrometry and the trinitrobenzene sulfonic acid method were adopted to assay the density of conjugates quantitatively. As a result, CPFX-BSA conjugates with various hapten densities (21-30 molecules per carrier protein) were obtained. After immunization in mice, ELISA tests showed that the antisera titer increased gradually with the increase of hapten density. The antibody obtained from the mice showed high sensitivity toward CPFX. These results revealed the relationship between hapten density and immunogenicity as well as an optimized conjugation approach for immunization purposes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621986

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  4 in total

1.  Optimization of a multivalent peptide vaccine for nicotine addiction.

Authors:  David F Zeigler; Richard Roque; Christopher H Clegg
Journal:  Vaccine       Date:  2019-02-13       Impact factor: 3.641

2.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

3.  Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.

Authors:  David F Zeigler; Richard Roque; Christopher H Clegg
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

4.  Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier.

Authors:  Keith D Miller; Richard Roque; Christopher H Clegg
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.